A Multi‐Center Double‐Blind Pilot Comparison of OnabotulinumtoxinA and Topiramate for the Prophylactic Treatment of Chronic Migraine (Q82424361)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070228%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070228%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

A Multi‐Center Double‐Blind Pilot Comparison of OnabotulinumtoxinA and Topiramate for the Prophylactic Treatment of Chronic Migraine (English)

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

24 August 2024

main subject

botulinum toxin type A

1 reference

Roger K. Cady

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21070228

24 August 2024

Curtis P. Schreiber

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21070228

24 August 2024

John A. H. Porter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21070228

24 August 2024

Andrew M. Blumenfeld

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21070228

24 August 2024

Kathleen U. Farmer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21070228

24 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21070228

24 August 2024

publication date

10 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070228%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 January 2020

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1526-4610.2010.01796.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21070228

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1526-4610.2010.01796.x

24 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1526-4610.2010.01796.x/fullpdf

24 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

24 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070228%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070228%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070228%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

21-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070228%20AND%20SRC:MED&resulttype=core&format=json

Divalproex sodium in migraine prophylaxis: a dose-controlled study

16 January 2020

cites work

2

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

Migraine prevalence, disease burden, and the need for preventive therapy

24 August 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

Topiramate in migraine prevention: results of a large controlled trial

24 August 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

Lamotrigine versus placebo in the prophylaxis of migraine with and without aura

24 August 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial

24 August 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study

24 August 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials

24 August 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

24 August 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

24 August 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

24 August 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study

24 August 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

New appendix criteria open for a broader concept of chronic migraine

24 August 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues

24 August 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

Placebo response in the prophylaxis of migraine: a meta-analysis.

24 August 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

A quantification of the placebo response in migraine prophylaxis

24 August 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience

24 August 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group

24 August 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.

24 August 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1526-4610.2010.01796.X

24 August 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070228%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference